ELUT – elutia, inc. - class a (US:NASDAQ)

News

Elutia (NASDAQ:ELUT) was upgraded by analysts at Wall Street Zen to
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
Elutia (NASDAQ:ELUT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com